ELDERPHARM Intraday Analysis...


Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A
52 Week Low N/A
ELDERPHARM Important Levels
Resistance 2 N/A
Resistance 1 N/A
Pivot N/A
Support 1 N/A
Support 2 N/A
NSE INDIA Most Active Stocks
AXISBANK 487.55 -7.85%
FEDERALBNK 82.00 0.99%
ICICIBANK 278.40 -3.75%
L&TFH 104.75 1.85%
ITC 238.75 0.00%
ITC 238.75 0.00%
JPASSOCIAT 11.30 -0.88%
GMRINFRA 13.85 4.92%
IDFCBANK 78.05 -0.26%
IDEA 78.70 4.52%
NSE INDIA Top Gainers Stocks
VISESHINFO 0.15 50.00%
PARASPETRO 0.25 25.00%
SEPOWER 9.60 20.00%
SAREGAMA 290.15 20.00%
POCHIRAJU 11.30 19.58%
PEARLPOLY 29.45 18.75%
GREENFIRE 1.90 18.75%
INFOMEDIA 6.20 14.81%
IGPL 267.25 14.45%
PRAENG 14.00 13.36%
NSE INDIA Top Losers Stocks
VKSPL 0.05 -50.00%
BIRLACOT 0.05 -50.00%
BHAGERIA 373.05 -47.50%
RASOYPR 0.15 -25.00%
RAJRAYON 0.30 -14.29%
VISASTEEL 19.10 -11.16%
ADVENZYMES 2143.10 -8.91%
KANANIIND 21.20 -8.82%
RAJOIL 2.60 -8.77%
MSPL 15.45 -8.31%

Elder Pharmaceuticals Limited (NSE: ELDERPHARM)

ELDERPHARM Technical Analysis 1
As on N/A ELDERPHARM Share Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
ELDERPHARM Target for October
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ELDERPHARM Synopsis Technicals View
50 Day EMA N/A (Short Term)
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
ADX (14) N/A N/A
10 Day Avg Volume N/A
ELDERPHARM Other Details
Segment BE
Market Capital 3598659840.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.elderindia.com
Elder House
C-9, Dalia Industrial Estate
Mumbai, 400053
Phone: 91 22 2673 0058
Fax: 91 22 2673 0051
Interactive Technical Analysis Chart Elder Pharmaceuticals Limited ( ELDERPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Elder Pharmaceuticals Limited
ELDERPHARM Business Profile
Elder Pharma is in the Pharmaceuticals sector. Elder Pharmaceuticals (EPL) was set up in 1987. The company is mainly into manufacture of bulk drugs and formulations. Elder has manufacturing facilities in Nerul, Pawane and Patalganga (all in the state of Maharashtra). Formulations and bulk drugs contribute almost 75% to the company`s revenues. In the year 1991, the company achieved R&D recognition from the Government of India.The mission of the company is to occupy a prominent place in national and international health care arena with focus on research and global collaborations. The group has three companies namely Elder Pharmaceutical, Elder HealthCare (EHC) and Elder Projects. The main therapeutic areas of interest for the company are osteoporosis and wound-care. The company has also positioned itself in the emerging markets of cardiology, respiratory disorders and cerebral diseases. Other areas of activity are dermatology, nutritional products and antioxidants. Bulk drugs manufactured like ampicillin trihydrate, amoxycillin trihydrate and cloxacillin sodium (oral) are mainly used for captive consumption in its own healthcare set up, surplus if any being sold in the domestic market or exported. EPL entered into alliances with foreign companies for manufacture and sale of their products under license from them. Besides, EPL has also introduced some of its own brands like Shelcal, Eldervit-12 INJ, Chymoral Forte, Amifru and I-VIT. It also has a presence in the OTC segment and sells the Tiger range of products from Singapore, SOLO Eucamenth tablets, AMPM mouthwash and toothbrushes. The company has tie up with Haw Par, Fugisawa and Paul Hartmann. The exports of company commenced in 1991 when it received its first order from Russia for Colloidal Bismuth Subcitrate (Denol) tablets. The company received the ``Certificate of Merit`` from the ministry of commerce, government of India for outstanding export performance during the period 1992-93. It enjoys an export house status since 1994 with shipment being made to African and South Asian countries. The company has diversified into sale of medical equipment. Export markets include Switzerland, Germany, England, Denmark and a few African countries. The current market capitalization stands at Rs 617.55 crore.The company has reported a consolidated sales of Rs 272.76 crore and a Net Profit of Rs 3.14 crore for the quarter ended September 2013. The company management includes Alok Saxena - Managing Director & CEO, Yusuf Karim Khan - Executive Director, R Srinivasan - Director, Joginder Singh Juneja - Director, Sailendra Narain - Director, Michael Bastian - Director, Saleem Shervani - Director, S Jayaram - Director, Edoardo Carlo Richter - Director, Urvashi Saxena - Director, James Mceuen - Additional Director. The Registered office is at Elder House, Plot No. C-9, Dalia Industrial Estate,,Off Veera Desai Road, Mumbai, Maharashtra - 400053.